Govt moves to fast-track domestic API production

With tension brewing between India and China, the Centre is readying guidelines to fast-track launch of the production-linked incentive (PLI) scheme to promote local manufacturing of active pharmaceutical ingredients (API) used in making medicine formulations. ​​India currently sources 70-80% of APIs and key starting material for drug formulation from China because of cost viability.